Evaluating the Safety of Zileuton (Zyflo®) in Combination With Dasatinib (Sprycel®) in Chronic Myelogenous Leukemia
|2||Not yet recruiting||
ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission
Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia
† Study has passed its completion date and status has not been verified in more than two years.